Genexine, Inc. (095700.KQ)

KRW 5590.0

(-3.79%)

Total Assets Summary of Genexine, Inc.

Genexine, Inc.'s latest annual total assets in 2023 was 376.58 Billion KRW , down -3.14% from previous year.
Genexine, Inc.'s latest quarterly total assets in 2024 Q1 was 365.38 Billion KRW , down -2.97% from previous quarter.
Genexine, Inc. reported annual total assets of 388.78 Billion KRW in 2022, down -38.95% from previous year.
Genexine, Inc. reported annual total assets of 636.86 Billion KRW in 2021, up 6.69% from previous year.
Genexine, Inc. reported quarterly total assets of 352.72 Billion KRW for 2024 Q2, down -3.47% from previous quarter.
Genexine, Inc. reported quarterly total assets of 393.02 Billion KRW for 2023 Q3, down -5.87% from previous quarter.

Annual Total Assets Chart of Genexine, Inc. (2023 - 2012)

Historical Annual Total Assets of Genexine, Inc. (2023 - 2012)

Year	Total Assets	Total Assets Growth
2023	376.58 Billion KRW	-3.14%
2022	388.78 Billion KRW	-38.95%
2021	636.86 Billion KRW	6.69%
2020	596.9 Billion KRW	66.65%
2019	358.17 Billion KRW	-4.44%
2018	374.81 Billion KRW	166.33%
2017	140.73 Billion KRW	-11.26%
2016	158.59 Billion KRW	11.61%
2015	142.1 Billion KRW	0.0%
2012	63.37 Billion KRW	0.0%

Year	Total Assets	Total Assets Growth
2024 Q1	365.38 Billion KRW	-2.97%
2024 Q2	352.72 Billion KRW	-3.47%
2023 Q3	393.02 Billion KRW	-5.87%
2023 Q2	417.55 Billion KRW	-5.07%
2023 Q1	439.85 Billion KRW	13.14%
2023 FY	376.58 Billion KRW	-3.14%
2023 Q4	376.58 Billion KRW	-4.18%
2022 Q2	472.53 Billion KRW	-5.18%
2022 Q1	498.33 Billion KRW	-21.75%
2022 FY	388.78 Billion KRW	-38.95%
2022 Q4	388.78 Billion KRW	-12.57%
2022 Q3	444.66 Billion KRW	-5.9%
2021 Q3	750.56 Billion KRW	-4.59%
2021 Q4	636.86 Billion KRW	-15.15%
2021 FY	636.86 Billion KRW	6.69%
2021 Q1	639.16 Billion KRW	7.08%
2021 Q2	786.66 Billion KRW	23.08%
2020 Q2	419.98 Billion KRW	22.27%
2020 FY	596.9 Billion KRW	66.65%
2020 Q4	596.9 Billion KRW	12.27%
2020 Q3	531.64 Billion KRW	26.59%
2020 Q1	343.49 Billion KRW	-4.1%
2019 Q4	358.17 Billion KRW	0.0%
2019 FY	358.17 Billion KRW	-4.44%
2018 FY	374.81 Billion KRW	166.33%
2017 FY	140.73 Billion KRW	-11.26%
2016 FY	158.59 Billion KRW	11.61%
2015 FY	142.1 Billion KRW	0.0%
2013 Q3	58.95 Billion KRW	0.0%
2012 FY	63.37 Billion KRW	0.0%

Peer Total Assets Comparison of Genexine, Inc.

Name	Total Assets	Total Assets Difference
HLB Co., Ltd.	751.72 Billion KRW	49.903%
iNtRON Biotechnology, Inc.	98.61 Billion KRW	-281.877%
BINEX Co., Ltd.	257.01 Billion KRW	-46.525%
Bioneer Corporation	315.48 Billion KRW	-19.367%
Anterogen.Co.,Ltd.	149.43 Billion KRW	-152.013%
MEDIPOST Co., Ltd.	449.39 Billion KRW	16.201%
CrystalGenomics, Inc.	243.11 Billion USD	-54.9%
Helixmith Co., Ltd	227.27 Billion KRW	-65.693%
Chabiotech Co.,Ltd.	1725.57 Billion KRW	78.176%
Medy-Tox Inc.	611.62 Billion KRW	38.428%
Peptron, Inc.	52.49 Billion KRW	-617.363%
Amicogen, Inc.	467.09 Billion KRW	19.377%
HLB Therapeutics Co.,Ltd.	200.79 Billion KRW	-87.548%
LegoChem Biosciences, Inc.	189.5 Billion KRW	-98.724%
ALTEOGEN Inc.	256.09 Billion KRW	-47.047%
PharmaResearch Co., Ltd.	535.28 Billion KRW	29.647%
SillaJen, Inc.	76.71 Billion KRW	-390.891%
JETEMA, Co., Ltd.	252.14 Billion KRW	-49.352%
OliX Pharmaceuticals,Inc	102.82 Billion KRW	-266.24%
Genomictree Inc.	132.84 Billion KRW	-183.48%
MedPacto, Inc.	80.47 Billion KRW	-367.958%
D&D Pharmatech	79.2 Billion KRW	-375.466%
EASY BIO,Inc.	172.04 Billion KRW	-118.893%
GI Innovation, Inc.	81.34 Billion KRW	-362.977%